Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate. The company’s Opal Computational Platform™ consists of an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease. 

PSP Investments

Longevity Vision Fund

Koch Disruptive Technologies

Atinum Investment

HBM Healthcare Investments AG

E Squared Capital Management

Invus

Flagship Pioneering

Mirae Asset Capital

Valo Health

Insitro is a company specializing in AI-powered drug discovery and development, similar to Valo. It is known for its innovative approaches in the pharmaceutical industry.

Insitro

Atomwise is a competitor of Valo, focusing on AI-powered drug discovery and development. It is recognized for its contributions to the pharmaceutical industry.

Atomwise

BERG is a key competitor of Valo, engaged in AI-driven drug discovery and development. It is a significant player in the pharmaceutical industry.

BERG

BioMap is a pioneer in AI foundation models for life sciences, focusing on understanding and predicting complex life behaviors and generating diverse proteins.

BioMap

Valo Health is a cutting-edge technology company focused on revolutionizing drug discovery and development through its Opal Computational Platform™, which combines machine learning, tissue biology, and patient data.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Mar 4, 2024 1:40 PM	ee4fdc61
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 1:40 PM	a3279693
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general
news basic	general	Mar 4, 2024 1:40 PM	a462076b
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:VALOHEALTH

Valo Health